Cardiovascular events following vascular endothelial growth factor inhibitor therapy with sunitinib or pazopanib in patients with renal cell carcinoma - a nationwide registry-based follow-up study

被引：0
|
作者：
Shanmuganathan, J. [1 ]
Schou, M. S. Morten [2 ]
Butt, J. H. B. Jawad Haider [3 ]
Torp-Pedersen, C. T. P. Christian [3 ]
Poulsen, L. O. P. Laurids Ostergaard [1 ]
Pareek, M. P. Manan [3 ]
Gislason, G. G. Gunnar [3 ]
Kober, L. K. Lars [3 ]
Nielsen, D. N. Dorte [2 ]
El-Galaly, T. C. E. Tarec Christoffer [1 ]
Soegaard, P. S. Peter [1 ]
Mamas, M. A. M. Mamas A. [4 ]
Freeman, P. F. Phillip [1 ]
Kragholm, K. H. K. Kristian Hay [1 ]
机构：
[1] Aalborg Univ Hosp, Aalborg, Denmark
[2] Herlev Hosp, Dept Cardiol, Herlev, Denmark
[3] Copenhagen Univ Hosp, Dept Cardiol, Rigshosp, Copenhagen, Denmark
[4] Keele Univ, Cardiol, Keele, Staffs, England
来源：
EUROPEAN HEART JOURNAL | 2023年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] The Impact of Cytoreductive Nephrectomy on Survival of Patients With Metastatic Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor Targeted Therapy EDITORIAL COMMENT
    Singer, Eric A.
    Srinivasan, Ramaprasad
    Bratslavsky, Gennady
    JOURNAL OF UROLOGY, 2011, 185 (01): : 66 - 66
  • [42] Vascular endothelial growth factor-targeted therapy in patients with renal cell carcinoma pretreated with immune checkpoint inhibitors: A systematic literature review
    Albiges, Laurence
    McGregor, Bradley A.
    Heng, Daniel Y. C.
    Procopio, Giuseppe
    de Velasco, Guillermo
    Taguieva-Pioger, Naila
    Martin-Couce, Lidia
    Tannir, Nizar M.
    Powles, Thomas
    CANCER TREATMENT REVIEWS, 2024, 122
  • [43] RECIST 1.1 Compared With RECIST 1.0 in Patients With Advanced Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor-Targeted Therapy
    Krajewski, Katherine M.
    Nishino, Mizuki
    Ramaiya, Nikhil H.
    Choueiri, Toni K.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2015, 204 (03) : W282 - W288
  • [44] Clinical Outcome in Metastatic Renal Cell Carcinoma Patients After Failure of Initial Vascular Endothelial Growth Factor-Targeted Therapy REPLY
    Vickers, Michael M.
    Heng, Daniel Y.
    Choueiri, Toni K.
    Rini, Brian I.
    UROLOGY, 2010, 76 (02) : 435 - 435
  • [45] Categories of response to first line vascular endothelial growth factor receptor targeted therapy and overall survival in patients with metastatic renal cell carcinoma
    Busch, Jonas
    Seidel, Christoph
    Goranova, Irena
    Erber, Barbara
    Peters, Robert
    Friedersdorff, Frank
    Magheli, Ahmed
    Miller, Kurt
    Gruenwald, Viktor
    Weikert, Steffen
    EUROPEAN JOURNAL OF CANCER, 2014, 50 (03) : 563 - 569
  • [46] Clinical factors associated with outcome in patients with metastatic clear-cell renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy
    Choueiri, Toni K.
    Garcia, Jorge A.
    Elson, Paul
    Khasawneh, Mohamad
    Usman, Saif
    Golshayan, Ali Reza
    Baz, Rachid C.
    Wood, Laura
    Rini, Brian I.
    Bukowski, Ronald M.
    CANCER, 2007, 110 (03) : 543 - 550
  • [47] Analyze of factors and prognosis of eyes lost to follow-up in retinal vein occlusive disease patients receiving anti-vascular endothelial growth factor therapy
    Huang, Xiaoying
    Zheng, Minming
    Lu, Jiatao
    Wang, Xi
    Zheng, Zheng
    BMC OPHTHALMOLOGY, 2023, 23 (01)
  • [48] Analyze of factors and prognosis of eyes lost to follow-up in retinal vein occlusive disease patients receiving anti-vascular endothelial growth factor therapy
    Xiaoying Huang
    Minming Zheng
    Jiatao Lu
    Xi Wang
    Zheng Zheng
    BMC Ophthalmology, 23
  • [49] Vascular endothelial growth factor (VEGF) therapy in metastatic renal cell carcinoma (mRCC): Differences between Asian and non-Asian patients.
    Wang, Ying
    Choueiri, Toni K.
    Lee, Jae-Lyun
    Tan, Min-Han
    Rha, Sun Young
    North, Scott A.
    Kollmannsberger, Christian K.
    Heng, Daniel Yick Chin
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [50] A phase 1 study of buparlisib and bevacizumab in patients with metastatic renal cell carcinoma progressing on vascular endothelial growth factor-targeted therapies
    McKay, Rana R.
    De Velasco, Guillermo
    Werner, Lillian
    Bellmunt, Joaquim
    Harshman, Lauren
    Sweeney, Christopher
    Rosenberg, Jonathan E.
    Hirsch, Michelle
    Signoretti, Sabina
    Van Allen, Eliezer M.
    Walsh, Meghara
    Vaishampayan, Ulka
    McDermott, David F.
    Choueiri, Toni K.
    CANCER, 2016, 122 (15) : 2389 - 2398
12345